Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2005-01-10 (21 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: FECAMP (76400), Seine-Maritime
PHARMACIE DE LA MARINE : revenue, balance sheet and financial ratios
PHARMACIE DE LA MARINE is a French company
founded 21 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in FECAMP (76400),
this company of category PME
shows in 2021 a revenue of 3.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA MARINE (SIREN 480479245)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
3 928 741 €
3 689 537 €
3 654 405 €
3 781 573 €
3 721 000 €
3 576 539 €
Net income
116 236 €
93 783 €
195 324 €
137 208 €
85 105 €
86 148 €
137 183 €
244 228 €
214 063 €
EBITDA
N/C
N/C
N/C
205 520 €
111 589 €
123 211 €
167 252 €
368 032 €
329 014 €
Net margin
N/C
N/C
N/C
3.5%
2.3%
2.4%
3.6%
6.6%
6.0%
Revenue and income statement
In 2024, PHARMACIE DE LA MARINE generates positive net income of 116 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 214 k€ -> 116 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
116 236 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
50.675%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.91%
Solvency indicators evolution PHARMACIE DE LA MARINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
143.358
112.883
111.334
107.511
102.147
87.014
68.38
64.023
50.675
Financial autonomy
34.571
39.979
39.94
40.015
41.771
43.678
48.066
47.772
51.91
Repayment capacity
5.458
4.354
7.242
9.19
10.536
5.246
None
None
None
Cash flow / Revenue
6.845%
7.484%
4.358%
3.348%
2.958%
4.983%
None%
None%
None%
Sector positioning
Debt ratio
50.672024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good
In 2024, the debt ratio of PHARMACIE DE LA MARINE (50.67) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
51.91%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of PHARMACIE DE LA MARINE (51.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA MARINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
543 491 €
-97 081 €
-105 960 €
-85 330 €
-127 695 €
-153 653 €
0 €
0 €
0 €
Inventory turnover (days)
31
0
0
0
0
0
0
0
0
Customer payment term (days)
8
0
0
0
0
0
0
0
0
Supplier payment term (days)
39
38
41
47
38
42
0
0
0
Positioning of PHARMACIE DE LA MARINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA MARINE is estimated at
1 622 740 €
(range 1 130 050€ - 2 427 712€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1130k€1622k€2427k€
1 622 740 €Range: 1 130 050€ - 2 427 712€
NAF 5 année 2024
Valuation method used
Net Income Multiple
116 236 €
×
14.0x
=1 622 740 €
Range: 1 130 051€ - 2 427 713€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA MARINE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA MARINE
What is the revenue of PHARMACIE DE LA MARINE ?
The revenue of PHARMACIE DE LA MARINE in 2021 is 3.9 M€.
Is PHARMACIE DE LA MARINE profitable?
Yes, PHARMACIE DE LA MARINE generated a net profit of 116 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA MARINE ?
The headquarters of PHARMACIE DE LA MARINE is located in FECAMP (76400), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE DE LA MARINE ?
The tax return of PHARMACIE DE LA MARINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA MARINE operate?
PHARMACIE DE LA MARINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart